Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of bactericidal activity

S. Halldórsson, T. Guðjónsson, M. Gottfreðsson, G. H. Guðmundsson, O. Baldursson (Reykjavík, Iceland)

Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Session: Best of lung epithelial cells 2008
Session type: Oral Presentation
Number: 1762
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Halldórsson, T. Guðjónsson, M. Gottfreðsson, G. H. Guðmundsson, O. Baldursson (Reykjavík, Iceland). Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of bactericidal activity. Eur Respir J 2008; 32: Suppl. 52, 1762

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018

Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017

Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006

The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004

Three-dimensional lung epithelial cells potentiate aminoglycoside efficacy by enhancing intracellular pH in Pseudomonas aeruginosa
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

The antimicrobial molecule elafin protects the lung against Staphylococcus aureus infection
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004


Pseudomonas aeruginosa influences the inflammatory response of primary bronchial epithelial cells to rhinovirus infection
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020



Biofilm production and adherence to airway epithelial cells of P. aeruginosa strains: effect of N-acetyl-cysteine
Source: Eur Respir J 2005; 26: Suppl. 49, 726s
Year: 2005

Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro
Source: Eur Respir J 2003; 21: 401-406
Year: 2003



Inhibitory activity of azithromycin on pseudomonas aeruginosa in biofilms
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003

Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018


ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells
Source: Eur Respir J 2008; 32: 1591-1598
Year: 2008



In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Intracellular accumulation and bactericidal activity of moxifloxacin and ciprofloxacin in primary respiratory epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002

Pseudomonas aeruginosa LasB subverts innate immunity in alveolar macrophages and epithelial cells
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018

Adherence of Pseudomonas aeruginosa to cystic fibrosis buccal epithelial cells
Source: ERJ Open Res, 3 (1) 00095-2016; 10.1183/23120541.00095-2016
Year: 2017



The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by P. aeruginosa
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008


The role of ceramide in the host defense against pseudomonas aeruginosa infection
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006

Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model
Source: Eur Respir J 2007; 29: 965-968
Year: 2007



Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004